Trial Profile
Exploratory trial of the systemic application of CIGB-128 (HeberPAG(R)) in Mycosis Fungoides, stages Ib to III
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Oct 2020
Price :
$35
*
At a glance
- Drugs Interferon-alpha-2b/interferon-gamma (Primary)
- Indications Mycosis fungoides
- Focus Adverse reactions
- Acronyms MYFIC
- 31 Jul 2013 Status changed from active, no longer recruiting to completed as reported by Cuban Clinical Trial Registry record.
- 11 Jul 2012 New trial record